Isotretinoin's teratogenicity and psychiatric risks require monthly safety monitoring. Clinit automates the checklist, lab reminders, and consent documentation for every patient on the drug.
Why Isotretinoin Monitoring Fails Without a System
Isotretinoin (Accutane/Roaccutane) is highly effective for nodular acne, but its teratogenicity makes it one of the most tightly regulated drugs in medicine. In Egypt, the expected monitoring includes monthly pregnancy tests for female patients of childbearing potential, monthly liver function tests, and periodic lipid panels. In practice, these are often incomplete.
What Clinit Automates
When a prescription for isotretinoin is initiated, Clinit:
- Creates a monitoring schedule — monthly lab reminders for LFT, lipids, β-hCG
- Sets a prescription lock — the next month's supply cannot be prescribed until the required labs are recorded in the system
- Tracks cumulative dose — the system calculates the running mg/kg total and flags when the 120–150 mg/kg target range is approaching
- Generates monthly consent documentation — a structured consent form that is signed at each visit and stored against the patient record
Psychiatric Screening
Clinit's AI screening prompts include validated depression screening (PHQ-9 items) at baseline and monthly. Any score above threshold generates an alert suggesting dermatologist–psychiatrist communication before continuing.
Patient Portal Integration
Patients receive automated reminders 5 days before their next lab appointment via WhatsApp. Lab results uploaded to the portal are reviewed against the monitoring thresholds automatically.
